Filing Details

Accession Number:
0000711377-17-000031
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-06 17:14:21
Reporting Period:
2017-10-06
Accepted Time:
2017-10-06 17:14:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-04 14,513 $28.67 883,725 No 4 M Direct
Common Stock Acquisiton 2017-10-04 2,218 $28.67 885,943 No 4 M Direct
Common Stock Disposition 2017-10-04 14,513 $78.32 871,430 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2012-10-04 18,000 $0.00 18,000 $28.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
254,425 2017-10-04 No 4 M Direct
Footnotes
  1. Options were granted on 10/4/2012, have five year lives, and vest in equal annual 20% installments on the first five anniversary dates of the grant
  2. The option plan provides for the exchange of outstanding options for shares in an amount equal to the employee's equity in the options held